These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27667176)

  • 1. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
    Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
    EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
    Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
    Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
    Griner NB; Young D; Chaudhary P; Mohamed AA; Huang W; Chen Y; Sreenath T; Dobi A; Petrovics G; Vishwanatha JK; Sesterhenn IA; Srivastava S; Tan SH
    Mol Cancer Res; 2015 Feb; 13(2):368-79. PubMed ID: 25344575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity.
    Riddick G; Kotliarova S; Rodriguez V; Kim HS; Linkous A; Storaska AJ; Ahn S; Walling J; Belova G; Fine HA
    Sci Rep; 2017 Mar; 7():43605. PubMed ID: 28256619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT5 downregulation is associated with poor prognosis in glioblastoma.
    Chen X; Xu Z; Zeng S; Wang X; Liu W; Qian L; Wei J; Yang X; Shen Q; Gong Z; Yan Y
    Cancer Biomark; 2019; 24(4):449-459. PubMed ID: 30909186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis.
    Zhou S; Yi T; Liu R; Bian C; Qi X; He X; Wang K; Li J; Zhao X; Huang C; Wei Y
    Mol Cell Proteomics; 2012 Jul; 11(7):M112.017988. PubMed ID: 22493182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of annexin A family in glioblastoma.
    Xu H; Wu X; Dou Y; Zheng W
    Ir J Med Sci; 2022 Aug; 191(4):1539-1547. PubMed ID: 34398393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
    Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
    J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis.
    Menadi S; Kucuk B; Cacan E
    Biochem Genet; 2024 Aug; 62(4):2721-2742. PubMed ID: 38001391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
    Gangoso E; Southgate B; Bradley L; Rus S; Galvez-Cancino F; McGivern N; Güç E; Kapourani CA; Byron A; Ferguson KM; Alfazema N; Morrison G; Grant V; Blin C; Sou I; Marques-Torrejon MA; Conde L; Parrinello S; Herrero J; Beck S; Brandner S; Brennan PM; Bertone P; Pollard JW; Quezada SA; Sproul D; Frame MC; Serrels A; Pollard SM
    Cell; 2021 Apr; 184(9):2454-2470.e26. PubMed ID: 33857425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
    Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
    PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.
    Segerman A; Niklasson M; Haglund C; Bergström T; Jarvius M; Xie Y; Westermark A; Sönmez D; Hermansson A; Kastemar M; Naimaie-Ali Z; Nyberg F; Berglund M; Sundström M; Hesselager G; Uhrbom L; Gustafsson M; Larsson R; Fryknäs M; Segerman B; Westermark B
    Cell Rep; 2016 Dec; 17(11):2994-3009. PubMed ID: 27974212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2.
    San IV; Prost G; Williams JA; Moss SE; Nuber UA
    Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.